Enlonstobart for squamous cell carcinoma of head and neck

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 28 Nov 2025: Trial registered, NCT07254585
  2. 12 Dec 2025: Trial started, NCT07254585

The trials

NCT07254585: SYS6010 Combined With Enlonstobart In Recurrent Or Metastatic Head And Neck Squamous Cell Carcinoma

State
Under way
Phase
Phase 2
People
110 planned
Started
12 Dec 2025
Primary completion
30 Jun 2028
Arms
Enlonstobart group
Results
None posted
  1. 28 Nov 2025: Trial registered
  2. 12 Dec 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Also known as Enlonstobart Injection.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.